Histopathology-validated machine learning radiographic biomarker for noninvasive discrimination between true progression and pseudo-progression in glioblastoma.
Akbari H, Rathore S, Bakas S, Nasrallah MP, Shukla G, Mamourian E, Rozycki M, Bagley SJ, Rudie JD, Flanders AE, Dicker AP, Desai AS, O'Rourke DM, Brem S, Lustig R, Mohan S, Wolf RL, Bilello M, Martinez-Lage M, Davatzikos C.
Akbari H, et al. Among authors: rudie jd.
Cancer. 2020 Jun 1;126(11):2625-2636. doi: 10.1002/cncr.32790. Epub 2020 Mar 4.
Cancer. 2020.
PMID: 32129893
Free PMC article.